PWPCM
PFE icon

Perella Weinberg Partners Capital Management’s Pfizer PFE Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-52,700
Closed -$12K – 61
2016
Q1 		$12K Buy
+52,700
New +$1.51M 0.01% 55

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Perella Weinberg Partners Capital Management's PFE Position: Q2 2016 in Review

Perella Weinberg Partners Capital Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 25,732 shares — an estimated $723K sold.

Perella Weinberg Partners Capital Management first reported a position in PFE in Q2 2013 and held it in 8 quarters. The position peaked at $6.37M in Q2 2013. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Perella Weinberg Partners Capital Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Perella Weinberg Partners Capital Management sold 25,732 Pfizer shares in Q2 2016, an estimated $723K.
  • Perella Weinberg Partners Capital Management first reported a position in Pfizer in Q2 2013 and held it in 8 quarters.
  • Perella Weinberg Partners Capital Management's Pfizer position peaked at $6.37M in Q2 2013.
  • 1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.